Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease

J Chem Neuroanat. 2011 Oct;42(2):118-26. doi: 10.1016/j.jchemneu.2011.06.007. Epub 2011 Jul 2.

Abstract

Alzheimer's disease (AD) is a devastating neurodegenerative disorder that threatens to reach epidemic proportions as our population ages. Although much research has examined molecular pathways associated with AD, relatively few such studies have focused on the disease's critical early stages. In a prior microarray study we correlated gene expression in hippocampus with degree of Alzheimer's disease and found close associations between upregulation of apparent glial transcription factor/epigenetic/tumor suppressor genes and incipient AD. The results suggested a new model in which AD pathology spreads along myelinated axons (Blalock et al., 2004). However, the microarray analyses were performed on RNA extracted from frozen hand-dissected hippocampal CA1 tissue blocks containing both gray and white matter, limiting the confidence with which transcriptional changes in gray matter could be distinguished from those in white matter. Here, we used laser capture microdissection (LCM) to exclude major white matter tracts while selectively collecting CA1 hippocampal gray matter from formalin-fixed, paraffin-embedded (FFPE) hippocampal sections of the same subjects assessed in our prior study. Microarray analyses of this gray matter-enriched tissue revealed many transcriptional changes similar to those seen in our past study and in studies by others, particularly for downregulated neuron-related genes. Additionally, the present analyses identified several previously undetected pathway alterations, including downregulation of molecules that stabilize ryanodine receptor Ca2+ release and upregulation of vasculature development. Conversely, we found a striking paucity of the upregulated changes in the putative glial and growth-related genes that had been strongly overrepresented in the prior mixed-tissue study. We conclude that FFPE tissue can be a reliable resource for microarray studies of brain tissue, that upregulation of growth-related epigenetic/transcription factors during incipient AD is predominantly localized in and around white matter (supporting our prior findings and model), and that novel alterations in vascular and ryanodine receptor-related pathways in gray matter are closely associated with incipient AD.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology*
  • Axons / metabolism
  • Axons / pathology*
  • Biomarkers / metabolism
  • Calcium Signaling / physiology
  • Epigenesis, Genetic / genetics
  • Female
  • Hippocampus / metabolism
  • Hippocampus / pathology*
  • Humans
  • Laser Capture Microdissection / methods*
  • Male
  • Neovascularization, Physiologic / physiology
  • Nerve Growth Factors / genetics
  • Neural Pathways / metabolism
  • Neural Pathways / pathology
  • Neurons / metabolism
  • Neurons / pathology*
  • Oligonucleotide Array Sequence Analysis / methods*
  • Ryanodine Receptor Calcium Release Channel / genetics
  • Transcription Factors / genetics

Substances

  • Biomarkers
  • Nerve Growth Factors
  • Ryanodine Receptor Calcium Release Channel
  • Transcription Factors